Your browser doesn't support javascript.
loading
Healthy lifestyle and the risk of lymphoma in the European Prospective Investigation into Cancer and Nutrition study.
Naudin, Sabine; Solans Margalef, Marta; Saberi Hosnijeh, Fatemeh; Nieters, Alexandra; Kyrø, Cecilie; Tjønneland, Anne; Dahm, Christina C; Overvad, Kim; Mahamat-Saleh, Yahya; Besson, Caroline; Boutron-Ruault, Marie-Christine; Kühn, Tilman; Canzian, Federico; Schulze, Matthias B; Peppa, Eleni; Karakatsani, Anna; Trichopoulou, Antonia; Sieri, Sabina; Masala, Giovana; Panico, Salvatore; Tumino, Rosario; Ricceri, Fulvio; Chen, Sairah L F; Barroso, Leila L; Huerta, José M; Sánchez, Maria-Jose; Ardanaz, Eva; Menéndez, Virginia; Amiano Exezarreta, Pilar; Spaeth, Florentin; Jerkeman, Mats; Jirstom, Karin; Schmidt, Julie A; Aune, Dagfinn; Weiderpass, Elisabete; Riboli, Elio; Vermeulen, Roel; Casabonne, Delphine; Gunter, Marc; Brennan, Paul; Ferrari, Pietro.
Afiliação
  • Naudin S; Nutritional Methodology and Biostatistics Group, International Agency for Research on Cancer, World Health Organization, Lyon, France.
  • Solans Margalef M; Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
  • Saberi Hosnijeh F; Research Group on Statistics, Econometrics and Health (GRECS), University of Girona, Girona, Spain.
  • Nieters A; Institute for Risk Assessment Sciences, Division of Environmental Epidemiology, Utrecht University, Utrecht, The Netherlands.
  • Kyrø C; Research Group Epidemiology, Institute for Immunodeficiency, Medical Center-University of Freiburg, Freiburg, Germany.
  • Tjønneland A; Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Dahm CC; Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Overvad K; Department of Public Health, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Mahamat-Saleh Y; Section for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark.
  • Besson C; Section for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark.
  • Boutron-Ruault MC; Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark.
  • Kühn T; CESP, Faculté de Médecine, Université Paris-Sud, UVSQ, INSERM, Université Paris-Saclay, Villejuif, France.
  • Canzian F; Gustave Roussy, Villejuif, France.
  • Schulze MB; CESP, Faculté de Médecine, Université Paris-Sud, UVSQ, INSERM, Université Paris-Saclay, Villejuif, France.
  • Peppa E; Department of Hematology and Oncology, Hospital of Versailles, Le Chesnay, France.
  • Karakatsani A; CESP, Faculté de Médecine, Université Paris-Sud, UVSQ, INSERM, Université Paris-Saclay, Villejuif, France.
  • Trichopoulou A; Gustave Roussy, Villejuif, France.
  • Sieri S; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Masala G; Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Panico S; Department of Molecular Epidemiology, German Institute of Human Nutrition, Nuthetal, Germany.
  • Tumino R; Institute of Nutrition Science, University of Potsdam, Nuthetal, Germany.
  • Ricceri F; Hellenic Health Foundation, Athens, Greece.
  • Chen SLF; Hellenic Health Foundation, Athens, Greece.
  • Barroso LL; Pulmonary Medicine Department, School of Medicine, National and Kapodistrian University of Athens, "ATTIKON" University Hospital, Haidari, Greece.
  • Huerta JM; Hellenic Health Foundation, Athens, Greece.
  • Sánchez MJ; Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Ardanaz E; Cancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network - ISPRO, Florence, Italy.
  • Menéndez V; Department of Clinical and Experimental Medicine, University Federico II, Naples, Italy.
  • Amiano Exezarreta P; Cancer Registry and Histopathology Department, Azienda Sanitaria Provinciale (ASP) Ragusa, Ragusa, Italy.
  • Spaeth F; Department of Clinical and Biological Sciences, University of Turin, Turin, Italy.
  • Jerkeman M; Unit of Epidemiology, Regional Health Service ASL TO3, Grugliasco (TO), Italy.
  • Jirstom K; Institutt for Samfunnsmedisin, Det Helsevitenskapelige fakultet, UiT, Norges Arktiske Universitet, Tromso, Norway.
  • Schmidt JA; Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO-IDIBELL), Barcelona, Spain.
  • Aune D; Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, Murcia, Spain.
  • Weiderpass E; Spanish Consortium for Research and Public Health (CIBERESP), Madrid, Spain.
  • Riboli E; Spanish Consortium for Research and Public Health (CIBERESP), Madrid, Spain.
  • Vermeulen R; Andalusian School of Public Health (EASP), Granada, Spain.
  • Casabonne D; Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Granada, Spain.
  • Gunter M; Universidad de Granada (UGR), Granada, Spain.
  • Brennan P; Spanish Consortium for Research and Public Health (CIBERESP), Madrid, Spain.
  • Ferrari P; Navarra Public Health Institute, Pamplona, Spain.
Int J Cancer ; 147(6): 1649-1656, 2020 09 15.
Article em En | MEDLINE | ID: mdl-32176325
ABSTRACT
Limited evidence exists on the role of modifiable lifestyle factors on the risk of lymphoma. In this work, the associations between adherence to healthy lifestyles and risks of Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL) were evaluated in a large-scale European prospective cohort. Within the European Prospective Investigation into Cancer and Nutrition (EPIC), 2,999 incident lymphoma cases (132 HL and 2,746 NHL) were diagnosed among 453,808 participants after 15 years (median) of follow-up. The healthy lifestyle index (HLI) score combined information on smoking, alcohol intake, diet, physical activity and BMI, with large values of HLI expressing adherence to healthy behavior. Cox proportional hazards models were used to estimate lymphoma hazard ratios (HR) and 95% confidence interval (CI). Sensitivity analyses were conducted by excluding, in turn, each lifestyle factor from the HLI score. The HLI was inversely associated with HL, with HR for a 1-standard deviation (SD) increment in the score equal to 0.78 (95% CI 0.66, 0.94). Sensitivity analyses showed that the association was mainly driven by smoking and marginally by diet. NHL risk was not associated with the HLI, with HRs for a 1-SD increment equal to 0.99 (0.95, 1.03), with no evidence for heterogeneity in the association across NHL subtypes. In the EPIC study, adherence to healthy lifestyles was not associated with overall lymphoma or NHL risk, while an inverse association was observed for HL, although this was largely attributable to smoking. These findings suggest a limited role of lifestyle factors in the etiology of lymphoma subtypes.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fumar / Comportamento Alimentar / Estilo de Vida Saudável / Linfoma Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fumar / Comportamento Alimentar / Estilo de Vida Saudável / Linfoma Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2020 Tipo de documento: Article